China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

Announcement on the Wholly-Owned Subsidiary Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd. Receiving the Approval Notice for the Supplemental Drug Application of Peritoneal Dialysis Solution (Lactic Acid) Series

· Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Wholly-Owned Subsidiary Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd. Receiving the Approval Notice for the Supplemental Drug Application of Peritoneal Dialysis Solution (Lactic Acid) Series

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis